STAAR Surgical Company (STAA)
Cash ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 183,038 | 86,480 | 199,706 | 152,453 | 119,968 |
| Short-term investments | US$ in thousands | 37,688 | 125,159 | — | — | — |
| Total current liabilities | US$ in thousands | 65,036 | 51,716 | 48,802 | 41,236 | 34,478 |
| Cash ratio | 3.39 | 4.09 | 4.09 | 3.70 | 3.48 |
December 31, 2023 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($183,038K
+ $37,688K)
÷ $65,036K
= 3.39
The cash ratio for STAAR Surgical Company has shown a relatively stable trend over the past five years, ranging from 3.39 to 4.09. This indicates that the company has a sufficient level of cash and cash equivalents to cover its current liabilities in the short term. A cash ratio above 1.0 indicates that the company can meet its short-term obligations using its readily available cash resources.
The company's cash ratio has been consistently above 1.0, reflecting a strong liquidity position and the ability to meet its current liabilities without relying heavily on external sources of financing. The slight fluctuations in the cash ratio over the years may be attributed to changes in cash holdings or short-term liabilities. Overall, the stable and relatively high cash ratio suggests that STAAR Surgical Company has a prudent approach to managing its liquidity and is well-positioned to navigate any short-term financial challenges.
Peer comparison
Dec 31, 2023